DE10399029I1 - Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren. - Google Patents

Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren.

Info

Publication number
DE10399029I1
DE10399029I1 DE2003199029 DE10399029C DE10399029I1 DE 10399029 I1 DE10399029 I1 DE 10399029I1 DE 2003199029 DE2003199029 DE 2003199029 DE 10399029 C DE10399029 C DE 10399029C DE 10399029 I1 DE10399029 I1 DE 10399029I1
Authority
DE
Germany
Prior art keywords
aminoadamantane
immune regulators
compounds
aminoadamantane compounds
neutrophils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2003199029
Other languages
English (en)
Inventor
F Elstner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz Pharma GmbH and Co KGaA
Original Assignee
Merz Pharma GmbH and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma GmbH and Co KGaA filed Critical Merz Pharma GmbH and Co KGaA
Application granted granted Critical
Publication of DE10399029I1 publication Critical patent/DE10399029I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2003199029 1995-08-25 1996-08-21 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren. Pending DE10399029I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531342A DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
PCT/EP1996/003678 WO1997007791A1 (en) 1995-08-25 1996-08-21 Use of aminoadamantane compounds as immunoregulators

Publications (1)

Publication Number Publication Date
DE10399029I1 true DE10399029I1 (de) 2004-01-08

Family

ID=7770407

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19531342A Expired - Fee Related DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
DE69626650T Expired - Fee Related DE69626650T2 (de) 1995-08-25 1996-08-21 Verwendung von aminoadamantan-verbindungen als immunregulatoren
DE2003199029 Pending DE10399029I1 (de) 1995-08-25 1996-08-21 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE19531342A Expired - Fee Related DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
DE69626650T Expired - Fee Related DE69626650T2 (de) 1995-08-25 1996-08-21 Verwendung von aminoadamantan-verbindungen als immunregulatoren

Country Status (21)

Country Link
US (2) US6172116B1 (de)
EP (2) EP1293201A3 (de)
JP (1) JPH11512093A (de)
KR (1) KR100392986B1 (de)
CN (1) CN1282452C (de)
AT (1) ATE234083T1 (de)
AU (1) AU718219B2 (de)
CA (1) CA2230159C (de)
CZ (1) CZ299356B6 (de)
DE (3) DE19531342B4 (de)
DK (1) DK0845984T3 (de)
EE (1) EE04261B1 (de)
ES (1) ES2193259T3 (de)
GE (1) GEP19991779B (de)
IL (1) IL123394A (de)
MX (1) MX217078B (de)
NO (1) NO319153B1 (de)
RU (1) RU2219916C2 (de)
UA (1) UA57711C2 (de)
WO (1) WO1997007791A1 (de)
ZA (1) ZA967137B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064420A2 (en) * 1999-04-28 2000-11-02 Queen's University At Kingston Compositions and methods for treating amyloidosis using sulphonate derivatives
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
EA200600428A1 (ru) * 2004-06-24 2007-04-27 Акционерное Общество "Олайнфарм" Иммуностимулирующее и интерфероногенное средство
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2604591A4 (de) * 2010-08-09 2015-07-22 Shionogi & Co Verfahren zur herstellung von aminoadamantyl-carbamatderivaten
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
AU2017301929B2 (en) 2016-07-27 2023-03-02 Corium Pharma Solutions, Inc. Memantine transdermal delivery systems
JP7469879B2 (ja) 2016-07-27 2024-04-17 コリウム， エルエルシー 経口送達と生物学的に同等である薬物動態を有する経皮送達システム
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450761A (en) * 1967-03-30 1969-06-17 Sun Oil Co 1-aminoethyldimethyladamantane
DE4014672A1 (de) * 1990-05-08 1991-11-14 Werner E G Prof Dr Mueller Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

Also Published As

Publication number Publication date
ES2193259T3 (es) 2003-11-01
WO1997007791A1 (en) 1997-03-06
IL123394A0 (en) 1998-09-24
UA57711C2 (uk) 2003-07-15
MX217078B (es) 2003-10-22
EE9800057A (et) 1998-08-17
CA2230159A1 (en) 1997-03-06
EP0845984A1 (de) 1998-06-10
ZA967137B (en) 1997-03-12
US6255348B1 (en) 2001-07-03
DK0845984T3 (da) 2003-06-23
DE19531342A1 (de) 1997-02-27
JPH11512093A (ja) 1999-10-19
US6172116B1 (en) 2001-01-09
CZ52498A3 (cs) 1999-04-14
NO980793D0 (no) 1998-02-25
EP0845984B1 (de) 2003-03-12
ATE234083T1 (de) 2003-03-15
KR100392986B1 (ko) 2003-11-17
CZ299356B6 (cs) 2008-07-02
DE69626650T2 (de) 2003-12-18
AU718219B2 (en) 2000-04-13
EP1293201A2 (de) 2003-03-19
EE04261B1 (et) 2004-04-15
GEP19991779B (en) 1999-10-05
EP1293201A3 (de) 2003-05-21
KR19990044096A (ko) 1999-06-25
MX9801496A (es) 1998-05-31
CA2230159C (en) 2008-02-26
AU6926396A (en) 1997-03-19
NO980793L (no) 1998-02-25
DE69626650D1 (de) 2003-04-17
NO319153B1 (no) 2005-06-27
CN1282452C (zh) 2006-11-01
RU2219916C2 (ru) 2003-12-27
IL123394A (en) 2004-07-25
CN1198669A (zh) 1998-11-11
DE19531342B4 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
DE10399029I1 (de) Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren.
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
DE59310085D1 (de) Indolocarbazol-imide und deren verwendung
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE69320858T2 (de) 2-Oxoethylderivate als Immunosuppressiva
DE60019904D1 (de) Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
DE69329503D1 (de) Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ATE66145T1 (de) Pharmazeutische verwendung aromatischer thioaether.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH24203A (th) อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
RU94034011A (ru) Способ лечения психического расстройства
ATE71091T1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.